Atlanta-based NeuroTrials Research is currently conducting a clinical research study of an investigational infusion for women with postpartum depression. Postpartum depression currently affects 1 in 7 women, and is the #1 complication from childbirth.
“Postpartum depression is much more than just feelings of wanting to hurt your baby,” said Dr. Craig Johnson, the primary investigator of the study. “It often manifests as severe confusion, loss of appetite, sadness, excessive worry, or insomnia. Because of the range of symptoms, up to fifty percent of postpartum depression cases go undiagnosed.”
Throughout pregnancy, hormone levels increase dramatically, and then abruptly drop in the first 24 hours following birth. Leading physicians throughout the postpartum community now believe this abrupt hormonal change is the cause of many postpartum depression cases. The hormonal infusion works to correct this imbalance. If approved, the hormonal infusion could usher in fast-acting treatment options to new mothers, with some early participants seeing improvements in as little as 24 hours.
NeuroTrials is currently enrolling participants for this study. Patients who are 18-45 years old, have had a baby in the last 6 months, feel they have had at least one major depressive episode since their baby's birth, and are otherwise in good health can contact NeuroTrials at 404-851-9934 for more information. Qualified study participants receive free medical evaluations, treatment and are compensated for their time and travel. For full study details, visit www.neurotrials.com/postpartum.
Media inquiries contact Staci Mink at 404-538-9284 or email@example.com
About NeuroTrials Research
Founded in 1997, NeuroTrials Research is an outpatient and inpatient research facility located in Atlanta. The clinic occupies 12,000 square feet, including a 15-bed, state-of-the-art sleep lab and inpatient clinical research unit, which is designed specifically for the comfort and safety of subjects participating in its clinical trials. Today, NeuroTrials has conducted more than 175 clinical trials on over 2,500 volunteers throughout the Atlanta metro area.